{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:28:19Z","timestamp":1794414499409,"version":"4.9.1"},"reference-count":158,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","award":["PhRMA 1506945"],"award-info":[{"award-number":["PhRMA 1506945"]}],"id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008519","name":"University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008519","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010249","name":"Indiana University School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007114","name":"Ralph W. and Grace M. Showalter Research Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010264","name":"Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010264","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.pharmthera.2026.109108","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:14:21Z","timestamp":1787958861000},"page":"109108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clusterin as a therapeutic agent: Bridging the gap in brain and eye research"],"prefix":"10.1016","volume":"288","author":[{"given":"Bushra","family":"Zaman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Soundararajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padmanabhan P.","family":"Pattabiraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman Y.","family":"Fouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0005","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/brainsci15040379","article-title":"TREM 2 in Parkinson\u2019s disease: A promising candidate gene for disease susceptibility and progression","volume":"15","author":"Alonge","year":"2025","journal-title":"Brain Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0010","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1167\/iovs.09-4853","article-title":"Identification of novel substrates for the serine protease HTRA1 in the human RPE Secretome","volume":"51","author":"An","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0015","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1074\/mcp.M600261-MCP200","article-title":"Clusterin expression in normal mucosa and colorectal cancer","volume":"6","author":"Andersen","year":"2007","journal-title":"Molecular & Cellular Proteomics"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0020","doi-asserted-by":"crossref","DOI":"10.1177\/1178641816686078","article-title":"Characterization of vitreous and aqueous proteome in humans with proliferative diabetic retinopathy and its clinical correlation","volume":"8","author":"Balaiya","year":"2017","journal-title":"Proteomics Insights"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138958","article-title":"Clusterin seals the ocular surface barrier in mouse dry eye","volume":"10","author":"Bauskar","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e41635","article-title":"Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer\u2019s disease","volume":"11","author":"Beiter","year":"2025","journal-title":"Heliyon"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3171\/jns.1996.85.3.0468","article-title":"Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat","volume":"85","author":"Bellander","year":"1996","journal-title":"Journal of Neurosurgery"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bbagrm.2014.11.003","article-title":"Distinct promoters, subjected to epigenetic regulation, drive the expression of two clusterin mRNAs in prostate cancer cells","volume":"1849","author":"Bonacini","year":"2015","journal-title":"Biochimica et Biophysica Acta"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0050","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/02713683.2019.1698055","article-title":"Evaluation of tear fluid and aqueous humor concentration of Clusterin as biomarkers for early diagnosis of Pseudoexfoliation syndrome and Pseudoexfoliative Glaucoma","volume":"45","author":"Can Demird\u00f6\u011fen","year":"2020","journal-title":"Current Eye Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0055","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mcna.2019.11.001","article-title":"Traumatic brain injury: An overview of epidemiology, pathophysiology, and medical management","volume":"104","author":"Capizzi","year":"2020","journal-title":"The Medical Clinics of North America"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109108_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26136351","article-title":"The emerging role of the molecular chaperone clusterin in Parkinson\u2019s disease","volume":"26","author":"Carini","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.99","article-title":"The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60","volume":"2","author":"Chaiwatanasirikul","year":"2011","journal-title":"Cell Death & Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0070","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroscience.2008.06.022","article-title":"Clusterin expression during fetal and postnatal CNS development in mouse","volume":"155","author":"Charnay","year":"2008","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1750-1326-7-41","article-title":"Mass spectrometry quantification of clusterin in the human brain","volume":"7","author":"Chen","year":"2012","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-021-00426-7","article-title":"Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer\u2019s disease neuropathology","volume":"16","author":"Chen","year":"2021","journal-title":"Molecular Neurodegeneration"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0085","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1038\/s41467-024-52142-7","article-title":"Astrocyte-derived clusterin disrupts glial physiology to obstruct remyelination in mouse models of demyelinating diseases","volume":"15","author":"Chen","year":"2024","journal-title":"Nature Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0090","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1161\/STROKEAHA.123.045957","article-title":"Eye toward stroke prevention: Central retinal artery occlusion and tandem internal carotid artery occlusion","volume":"55","author":"Cheronis","year":"2024","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0100","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/ijms24020981","article-title":"Recombinant human clusterin seals damage to the ocular surface barrier in a mouse model of ophthalmic preservative-induced epitheliopathy","volume":"24","author":"Chintala","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0105","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.jbchem.a123938","article-title":"Identification of the disulfide bonds in human plasma protein SP-40,40 (apolipoprotein-J)1","volume":"112","author":"Choi-Miura","year":"1992","journal-title":"Journal of Biochemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s44386-025-00009-2","article-title":"Discovery of a small molecule secreted clusterin enhancer that improves memory in Alzheimer\u2019s disease mice","volume":"2","author":"Cohn","year":"2025","journal-title":"NPJ Drug Discovery"},{"issue":"23","key":"10.1016\/j.pharmthera.2026.109108_bb0120","doi-asserted-by":"crossref","first-page":"14682","DOI":"10.1073\/pnas.222551899","article-title":"Drusen proteome analysis: An approach to the etiology of age-related macular degeneration","volume":"99","author":"Crabb","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"The Ocular Surface"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0130","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.113","article-title":"Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses","volume":"7","author":"Cunin","year":"2016","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0135","doi-asserted-by":"crossref","first-page":"20208","DOI":"10.1038\/s41598-019-56683-6","article-title":"Dynamics of clusterin protein expression in the brain and plasma following experimental traumatic brain injury","volume":"9","author":"Das Gupta","year":"2019","journal-title":"Scientific Reports"},{"issue":"7889","key":"10.1016\/j.pharmthera.2026.109108_bb0140","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41586-021-04183-x","article-title":"Exercise plasma boosts memory and dampens brain inflammation via clusterin","volume":"600","author":"De Miguel","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13195-019-0498-8","article-title":"Peripheral administration of human recombinant ApoJ\/clusterin modulates brain beta-amyloid levels in APP23 mice","volume":"11","author":"de Retana","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0155","doi-asserted-by":"crossref","first-page":"208.e1","DOI":"10.1016\/j.neurobiolaging.2015.09.009","article-title":"A potential endophenotype for Alzheimer\u2019s disease: Cerebrospinal fluid clusterin","volume":"37","author":"Deming","year":"2016","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0160","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12886-023-02850-3","article-title":"Influence of clusterin genetic variants on IOP elevation in pseudoexfoliation syndrome and pseudoexfoliative glaucoma in Turkish population","volume":"23","author":"Demird\u00f6\u011fen","year":"2023","journal-title":"BMC Ophthalmology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0165","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1167\/iovs.05-0736","article-title":"Detection of differentially expressed Glycogenes in trabecular meshwork of eyes with primary open-angle Glaucoma","volume":"47","author":"Diskin","year":"2006","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.7150\/ijms.107159","article-title":"Clusterin: Structure, function and roles in disease","volume":"22","author":"Du","year":"2025","journal-title":"International Journal of Medical Sciences"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109108_bb0175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.3109\/02713683.2014.997884","article-title":"Evaluation of genetic polymorphisms in Clusterin and tumor necrosis factor-alpha genes in south Indian individuals with Pseudoexfoliation syndrome","volume":"40","author":"Dubey","year":"2015","journal-title":"Current Eye Research"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0180","first-page":"66","article-title":"Anterior segment alterations and comparative aqueous humor proteomics in the buphthalmic rabbit (an American ophthalmological society thesis)","volume":"109","author":"Edward","year":"2011","journal-title":"Transactions of the American Ophthalmological Society"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s00018-023-04848-y","article-title":"The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj\u2212\/\u2212 mice","volume":"80","author":"El-Darzi","year":"2023","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0190","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1479-7364-6-22","article-title":"Pseudoexfoliation syndrome, a systemic disorder with ocular manifestations","volume":"6","author":"Elhawy","year":"2012","journal-title":"Human Genomics"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0195","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1074\/jbc.C109.057133","article-title":"Identification of clusterin domain involved in NF-kappaB pathway regulation","volume":"285","author":"Essabbani","year":"2010","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0200","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exer.2015.08.004","article-title":"Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis","volume":"139","author":"Fan","year":"2015","journal-title":"Experimental Eye Research"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0205","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/biom12101452","article-title":"The role of Clusterin transporter in the pathogenesis of Alzheimer\u2019s disease at the blood-brain barrier interface: A systematic review","volume":"12","author":"Fareed","year":"2022","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0210","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nature Reviews. Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0215","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/glia.23920","article-title":"Extracellular clusterin limits the uptake of \u03b1-synuclein fibrils by murine and human astrocytes","volume":"69","author":"Filippini","year":"2021","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0220","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ijms22010116","article-title":"Therapeutic potential of the molecular chaperone and matrix metalloproteinase inhibitor Clusterin for dry eye","volume":"22","author":"Fini","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0225","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer\u2019s disease: Mechanisms, genetics, and lessons from other pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0235","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1038\/s41598-026-40211-4","article-title":"Clusterin reverses epitheliopathy, reduces inflammation, and restores goblet cells and corneal nerves in a mouse model of autoimmune dry eye","volume":"16","author":"Franz","year":"2026","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0240","article-title":"Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway","volume":"4","author":"Gil","year":"2013","journal-title":"Nature Communications"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109108_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212426","article-title":"Contribution of the transcription factors Sp1\/Sp3 and AP-1 to Clusterin gene expression during corneal wound healing of tissue-engineered human corneas","volume":"22","author":"Gross","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109108_bb0250","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713182","article-title":"The ins and outs of clusterin: Its role in cancer, eye diseases and wound healing","volume":"24","author":"Gross","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0255","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1016\/j.jns.2015.08.1352","article-title":"Serum and urine clusterin levels are elevated in stroke patients","volume":"357","author":"Guido","year":"2015","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0260","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/glia.20021","article-title":"Expression of clusterin in M\u00fcller cells of the rat retina after pressure-induced ischemia","volume":"47","author":"Gwon","year":"2004","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0265","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/prca.200780077","article-title":"Protein content in aqueous humor from patients with pseudoexfoliation (PEX) investigated by capillary LC MALDI-TOF\/TOF MS","volume":"3","author":"Hardenborg","year":"2009","journal-title":"Proteomics. Clinical Applications"},{"issue":"7356","key":"10.1016\/j.pharmthera.2026.109108_bb0270","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0275","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.48255","article-title":"Brain clusterin protein isoforms and mitochondrial localization","volume":"8","author":"Herring","year":"2019","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0285","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/jnc.13491","article-title":"Intraventricular apolipoprotein ApoJ infusion acts protectively in traumatic brain injury","volume":"136","author":"Huang","year":"2016","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/03009734.2019.1646359","article-title":"Clusterin as a potential marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy","volume":"124","author":"I\u0142\u017cecka","year":"2019","journal-title":"UJMS"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0295","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201911126","article-title":"Heparan sulfate is a clearance receptor for aberrant extracellular proteins","volume":"219","author":"Itakura","year":"2020","journal-title":"The Journal of Cell Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0300","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcz003","article-title":"Clusterin accumulates in synapses in Alzheimer\u2019s disease and is increased in apolipoprotein E4 carriers","volume":"1","author":"Jackson","year":"2019","journal-title":"Brain Communications"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0305","first-page":"2421","article-title":"Expression analysis of human pterygium shows a predominance of conjunctival and limbal markers and genes associated with cell migration","volume":"15","author":"Jaworski","year":"2009","journal-title":"Molecular Vision"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0310","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ajpath.2012.01.025","article-title":"Interaction of Clusterin and matrix Metalloproteinase-9 and its implication for epithelial homeostasis and inflammation","volume":"180","author":"Jeong","year":"2012","journal-title":"The American Journal of Pathology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0315","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0169-328X(93)90052-Q","article-title":"Abnormal distribution of retinal clusterin in retinitis pigmentosa","volume":"20","author":"Jomary","year":"1993","journal-title":"Molecular Brain Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-5793(92)80863-C","article-title":"Analysis of differentially expressed genes in retinitis pigmentosa retinas. Altered expression of clusterin mRNA","volume":"300","author":"Jones","year":"1992","journal-title":"FEBS Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0325","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-150036","article-title":"Clusterin levels in plasma predict cognitive decline and progression to Alzheimer\u2019s disease","volume":"46","author":"Jongbloed","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0330","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exer.2011.01.003","article-title":"Retinal pigment epithelial cells upregulate expression of complement factors after co-culture with activated T cells","volume":"92","author":"Juel","year":"2011","journal-title":"Experimental Eye Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0335","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1167\/iovs.07-1405","article-title":"Increased Clusterin expression in Fuchs\u2019 endothelial dystrophy","volume":"49","author":"Jurkunas","year":"2008","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0340","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1167\/iovs.08-2525","article-title":"Colocalization of increased transforming growth factor-\u03b2-induced protein (TGFBIp) and Clusterin in Fuchs endothelial corneal dystrophy","volume":"50","author":"Jurkunas","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0345","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/pro.5560061007","article-title":"Identification and characterization of glycosylation sites in human serum clusterin","volume":"6","author":"Kapron","year":"1997","journal-title":"Protein Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagrm.2023.194980","article-title":"Role of clusterin gene 3\u2019-UTR polymorphisms and promoter hypomethylation in the pathogenesis of pseudoexfoliation syndrome and pseudoexfoliation glaucoma","volume":"1866","author":"Kapuganti","year":"2023","journal-title":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.exer.2011.11.014","article-title":"Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene","volume":"96","author":"Karring","year":"2012","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0360","doi-asserted-by":"crossref","first-page":"169","DOI":"10.5115\/acb.2011.44.3.169","article-title":"Proapoptotic role of nuclear clusterin in brain","volume":"44","author":"Kim","year":"2011","journal-title":"Anatomy & Cell Biology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0365","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.09-3615","article-title":"Protective effect of Clusterin on blood\u2013retinal barrier breakdown in diabetic retinopathy","volume":"51","author":"Kim","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0370","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1167\/iovs.09-3774","article-title":"Protective effect of clusterin from oxidative stress-induced apoptosis in human retinal pigment epithelial cells","volume":"51","author":"Kim","year":"2010","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aec9991","article-title":"Immunometabolic resistors of aging in long-lived golden spiny mice","volume":"12","author":"Kim","year":"2026","journal-title":"Science Advances"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1041961","article-title":"Overview of myelin, major myelin lipids, and myelin-associated proteins","volume":"10","author":"Kister","year":"2023","journal-title":"Frontiers in Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1103097","article-title":"The clusterin connectome: Emerging players in chondrocyte biology and putative exploratory biomarkers of osteoarthritis","volume":"14","author":"Kov\u00e1cs","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0390","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.5b07522","article-title":"High-density lipoproteins (HDL) - Nature\u2019s multi-functional nanoparticles","volume":"10","author":"Kuai","year":"2016","journal-title":"ACS Nano"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0395","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ejhg.2011.248","article-title":"Association of TCF4 and CLU polymorphisms with Fuchs\u2019 endothelial dystrophy and implication of CLU and TGFBI proteins in the disease process","volume":"20","author":"Kuot","year":"2012","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0400","article-title":"Sex differences in progressive multiple sclerosis brain gene expression in oligodendrocytes and OPCs","author":"LaBarre","year":"2025","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0405","doi-asserted-by":"crossref","DOI":"10.1111\/nan.70037","article-title":"Intrahippocampally injected human recombinant clusterin reduces amyloid-\u03b2 aggregate size in cerebral arteriole walls of clusterin knockout mice","volume":"51","author":"Laslo","year":"2025","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0410","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1074\/jbc.M113.529271","article-title":"Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway","volume":"289","author":"Leeb","year":"2014","journal-title":"The Journal of Biological Chemistry"},{"issue":"46","key":"10.1016\/j.pharmthera.2026.109108_bb0415","doi-asserted-by":"crossref","first-page":"40083","DOI":"10.1074\/jbc.M111.252957","article-title":"CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor","volume":"286","author":"Leskov","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0420","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.2147\/JIR.S469651","article-title":"Myeloid cell Trim59 deficiency worsens experimental ischemic stroke and alters cerebral proteomic profile","volume":"17","author":"Li","year":"2024","journal-title":"Journal of Inflammation Research"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109108_bb0425","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.neuron.2025.03.034","article-title":"CLU alleviates Alzheimer\u2019s disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density","volume":"113","author":"Lish","year":"2025","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0435","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0440","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41392-022-01157-x","article-title":"Clusterin transduces Alzheimer-risk signals to amyloidogenesis","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12031-022-02094-8","article-title":"Lysine demethylase 1B promotes tear secretion disorder in Sjogren\u2019s syndrome by regulating the PAX6\/CLU Axis","volume":"73","author":"Liu","year":"2023","journal-title":"Journal of Molecular Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0450","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain \u2014 From eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nature Reviews Neurology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0455","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3390\/biomedicines10051206","article-title":"TGF-\u03b2 as a key modulator of astrocyte reactivity: Disease relevance and therapeutic implications","volume":"10","author":"Luo","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0460","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1654","article-title":"Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis","volume":"14","author":"Malhotra","year":"2024","journal-title":"Clinical and Translational Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109108_bb0465","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/cells13080665","article-title":"Therapeutic potential of Clusterin inhibition in human cancer","volume":"13","author":"Mart\u00edn-Garc\u00eda","year":"2024","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0470","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.0610155104","article-title":"Controlled expression of transgenes introduced by in vivo electroporation","volume":"104","author":"Matsuda","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0475","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.64.5.13","article-title":"The presence of Guttae in Fuchs endothelial corneal dystrophy explants correlates with cellular markers of disease progression","volume":"64","author":"M\u00e9thot","year":"2023","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0485","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1167886","article-title":"Clusterin\/apolipoprotein J, its isoforms and Alzheimer\u2019s disease","volume":"15","author":"Milinkeviciute","year":"2023","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0490","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/bpa.12392","article-title":"Clusterin levels are increased in Alzheimer\u2019s disease and influence the regional distribution of A\u03b2","volume":"27","author":"Miners","year":"2017","journal-title":"Brain Pathology"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0495","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4103\/1673-5374.301013","article-title":"Clusterin: A multifaceted protein in the brain","volume":"16","author":"Moon","year":"2021","journal-title":"Neural Regeneration Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0500","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1172\/JCI113531","article-title":"SP-40,40, a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis","volume":"81","author":"Murphy","year":"1988","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0505","first-page":"1702","article-title":"Changes in conjunctival Clusterin expression in severe ocular surface disease","volume":"43","author":"Nakamura","year":"2002","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0510","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/bjo.83.10.1178","article-title":"Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies","volume":"83","author":"Nishida","year":"1999","journal-title":"The British Journal of Ophthalmology"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0515","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.exer.2016.01.001","article-title":"Proteomics of vitreous in neovascular age-related macular degeneration","volume":"146","author":"Nobl","year":"2016","journal-title":"Experimental Eye Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0520","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/neu.480240402","article-title":"Clusterin levels increase during neuronal development","volume":"24","author":"O\u2019Bryan","year":"1993","journal-title":"Journal of Neurobiology"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0525","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/089771503322385827","article-title":"Complement activation following optic nerve crush in the adult rat","volume":"20","author":"Ohlsson","year":"2003","journal-title":"Journal of Neurotrauma"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0535","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1167\/iovs.10-6348","article-title":"Clusterin promotes corneal epithelial cell growth through upregulation of hepatocyte growth factor by mesenchymal cells in vitro","volume":"52","author":"Okada","year":"2011","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0540","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1167\/iovs.06-0411","article-title":"Proteomic analysis of exfoliation deposits","volume":"48","author":"Ovodenko","year":"2007","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109108_bb0545","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1093\/hmg\/ddx329","article-title":"Pseudoexfoliation and Alzheimer\u2019s associated CLU risk variant, rs2279590, lies within an enhancer element and regulates CLU, EPHX2 and PTK2B gene expression","volume":"26","author":"Padhy","year":"2017","journal-title":"Human Molecular Genetics"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0550","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1007\/s12035-023-03801-1","article-title":"Clusterin is a potential therapeutic target in Alzheimer\u2019s disease","volume":"61","author":"Palihati","year":"2024","journal-title":"Molecular Neurobiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0555","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/cne.903390307","article-title":"Clusterin (SGP-2): A multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain","volume":"339","author":"Pasinetti","year":"1994","journal-title":"The Journal of Comparative Neurology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0560","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-010-0462-z","article-title":"CSF markers of neurodegeneration in Parkinson\u2019s disease","volume":"117","author":"P\u0159ikrylov\u00e1 Vranov\u00e1","year":"2010","journal-title":"Journal of Neural Transmission"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075303","article-title":"Non-secreted Clusterin isoforms are translated in rare amounts from distinct human mRNA variants and do not affect Bax-mediated apoptosis or the NF-\u03baB signaling pathway","volume":"8","author":"Prochnow","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0570","series-title":"Pipeline, our lead drug product","author":"Proteris Biotech","year":"2024"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0575","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.71177","article-title":"Five-decade mortality trends in ischemic stroke in the United States: A CDC WONDER analysis","volume":"16","author":"Qasim","year":"2026","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0580","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12868-018-0402-7","article-title":"Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer\u2019s disease","volume":"19","author":"Qi","year":"2018","journal-title":"BMC Neuroscience"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0585","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JAD-160663","article-title":"Neuroprotective effect of TREM-2 in aging and Alzheimer\u2019s disease model","volume":"55","author":"Raha","year":"2017","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109108_bb0590","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1021\/bi952981b","article-title":"Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J\/clusterin in epithelial cells","volume":"35","author":"Reddy","year":"1996","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158001","article-title":"Proteomic analysis of vitreous humor in retinal vein occlusion","volume":"11","author":"Reich","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0600","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.10.18","article-title":"Analysis of the aqueous humor proteome in patients with age-related macular degeneration","volume":"62","author":"Rinsky","year":"2021","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0605","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/jcp.21671","article-title":"Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells","volume":"219","author":"Rizzi","year":"2009","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111174","article-title":"Clusterin: Always protecting. Synthesis, function and potential issues","volume":"134","author":"Rodr\u00edguez-Rivera","year":"2021","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0615","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mds.27949","article-title":"CLU rs11136000 promotes early cognitive decline in Parkinson\u2019s disease","volume":"35","author":"Sampedro","year":"2020","journal-title":"Movement Disorders"},{"issue":"7846","key":"10.1016\/j.pharmthera.2026.109108_bb0620","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41586-020-03116-4","article-title":"Gut-licensed IFN\u03b3(+) NK cells drive LAMP1(+)TRAIL(+) anti-inflammatory astrocytes","volume":"590","author":"Sanmarco","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0625","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1107295","article-title":"Proteomics profiling of vitreous humor reveals complement and coagulation components, adhesion factors, and neurodegeneration markers as discriminatory biomarkers of vitreoretinal eye diseases","volume":"14","author":"Santos","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0630","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-002-0546-4","article-title":"Clusterin\/apolipoprotein J is associated with cortical Lewy bodies: Immunohistochemical study in cases with \u03b1-synucleinopathies","volume":"104","author":"Sasaki","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109108_bb0635","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/jama.2011.381","article-title":"Plasma clusterin and the risk of Alzheimer disease","volume":"305","author":"Schrijvers","year":"2011","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109108_bb0640","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1167\/tvst.13.8.30","article-title":"Proteomic analysis of aqueous humor in central retinal artery occlusion: Unveiling novel insights into disease pathophysiology","volume":"13","author":"Shahror","year":"2024","journal-title":"Translational Vision Science & Technology"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0645","first-page":"801","article-title":"Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry","volume":"24","author":"Sharma","year":"2018","journal-title":"Molecular Vision"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0650","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/10738584241254118","article-title":"Microglia, Trem2, and neurodegeneration","volume":"31","author":"Shi","year":"2025","journal-title":"Neuroscientist"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0655","first-page":"2789","article-title":"Protective effect of clusterin on oxidative stress-induced cell death of human corneal endothelial cells","volume":"15","author":"Shin","year":"2009","journal-title":"Molecular Vision"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0660","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s43587-026-01078-2","article-title":"Structural signature of plasma proteins classifies the status of Alzheimer\u2019s disease","volume":"6","author":"Son","year":"2026","journal-title":"Nature Aging"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0665","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3892\/or.2013.2764","article-title":"Anti-apoptotic effect of clusterin on cisplatin-induced cell death of retinoblastoma cells","volume":"30","author":"Song","year":"2013","journal-title":"Oncology Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0670","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s12975-018-0675-2","article-title":"From analysis of ischemic mouse brain proteome to identification of human serum Clusterin as a potential biomarker for severity of acute ischemic stroke","volume":"10","author":"Song","year":"2019","journal-title":"Translational Stroke Research"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0680","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/jcp.30769","article-title":"Novel insight into the role of clusterin on intraocular pressure regulation by modifying actin polymerization and extracellular matrix remodeling in the trabecular meshwork","volume":"237","author":"Soundararajan","year":"2022","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0685","article-title":"Proteomic analysis uncovers clusterin-mediated disruption of actin-based contractile machinery in the trabecular meshwork to lower intraocular pressure","author":"Soundararajan","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166384","article-title":"Clusterin in Alzheimer\u2019s disease: An amyloidogenic inhibitor of amyloid formation?","volume":"1868","author":"Spatharas","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0700","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3892\/etm.2017.4085","article-title":"Immunohistochemical analysis of microsomal glutathione S-transferase 1 and clusterin expression in lens epithelial cells of patients with pseudoexfoliation syndrome","volume":"13","author":"Stafiej","year":"2017","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"Suppl. 2","key":"10.1016\/j.pharmthera.2026.109108_bb0705","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1017\/S0317167100022393","article-title":"Multiple sclerosis: Autoimmune disease or autoimmune reaction?","volume":"37","author":"Stys","year":"2010","journal-title":"The Canadian Journal of Neurological Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0710","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbrc.2007.03.135","article-title":"Epigenetic regulation of clusterin\/apolipoprotein J expression in retinal pigment epithelial cells","volume":"357","author":"Suuronen","year":"2007","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109108_bb0715","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archgenpsychiatry.2010.78","article-title":"Association of Plasma Clusterin concentration with severity, pathology, and progression in Alzheimer disease","volume":"67","author":"Thambisetty","year":"2010","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0720","series-title":"Anonymous StatPearls","article-title":"Anatomy, central nervous system","author":"Thau","year":"2025"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/neup.12320","article-title":"Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury","volume":"37","author":"Troakes","year":"2017","journal-title":"Neuropathology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109108_bb0730","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000351207","article-title":"The molecular chaperone apolipoprotein J\/clusterin as a sensor of oxidative stress: Implications in therapeutic approaches - A mini-review","volume":"59","author":"Trougakos","year":"2013","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0735","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002611","article-title":"Common genetic determinants of intraocular pressure and primary open-angle glaucoma","volume":"8","author":"van Koolwijk","year":"2012","journal-title":"PLoS Genetics"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109108_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182389","article-title":"Protective effect of clusterin on rod photoreceptor in rat model of retinitis pigmentosa","volume":"12","author":"Vargas","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147575","article-title":"Clusterin enhances cell survival by suppressing neuronal nitric-oxide synthase expression in the rhodopsin S334ter-line3 retinitis pigmentosa model","volume":"1768","author":"Vargas","year":"2021","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0755","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1477-5956-10-15","article-title":"Characterisation of the vitreous proteome in proliferative diabetic retinopathy","volume":"10","author":"Wang","year":"2012","journal-title":"Proteome Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0760","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nm0901-977","article-title":"Inhibition of post-ischemic brain injury by clusterin overexpression","volume":"7","author":"Wehrli","year":"2001","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0765","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/imcb.12405","article-title":"Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys","volume":"99","author":"Weng","year":"2021","journal-title":"Immunology and Cell Biology"},{"issue":"7796","key":"10.1016\/j.pharmthera.2026.109108_bb0770","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41586-020-1999-0","article-title":"MAFG-driven astrocytes promote CNS inflammation","volume":"578","author":"Wheeler","year":"2020","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.pharmthera.2026.109108_bb0775","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.celrep.2018.05.074","article-title":"Single-molecule characterization of the interactions between extracellular chaperones and toxic \u03b1-Synuclein oligomers","volume":"23","author":"Whiten","year":"2018","journal-title":"Cell Reports"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0780","article-title":"Clusterin, other extracellular chaperones, and eye disease","volume":"89","author":"Wilson","year":"2021","journal-title":"Progress in Retinal and Eye Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109108_bb0785","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1076\/ceyr.23.3.157.5463","article-title":"Expression of multiple forms of clusterin during light-induced retinal degeneration","volume":"23","author":"Wong","year":"2001","journal-title":"Current Eye Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0790","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12886-020-01781-7","article-title":"Evaluation of aqueous humor and serum clusterin levels in patients with glaucoma","volume":"21","author":"Yavrum","year":"2021","journal-title":"BMC Ophthalmology"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109108_bb0795","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1167\/iovs.07-1003","article-title":"Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF-\u03b2 release","volume":"50","author":"Yu","year":"2009","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0805","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jtos.2018.08.001","article-title":"Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results","volume":"16","author":"Yu","year":"2018","journal-title":"The Ocular Surface"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109108_bb0810","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1038\/s41594-025-01631-4","article-title":"Structural analyses define the molecular basis of clusterin chaperone function","volume":"32","author":"Yuste-Checa","year":"2025","journal-title":"Nature Structural & Molecular Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109108_bb0815","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/mrd.1080330403","article-title":"Developmental expression of the S35-S45\/SGP-2\/TRPM-2 gene in rat testis and epididymis","volume":"33","author":"Zakeri","year":"1992","journal-title":"Molecular Reproduction and Development"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109108_bb0820","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1167\/iovs.05-1580","article-title":"Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material","volume":"47","author":"Zenkel","year":"2006","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109108_bb0825","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1291","article-title":"Clusterin inhibits apoptosis by interacting with activated Bax","volume":"7","author":"Zhang","year":"2005","journal-title":"Nature Cell Biology"},{"issue":"116","key":"10.1016\/j.pharmthera.2026.109108_bb0830","first-page":"227","article-title":"The emerging roles of clusterin on reduction of both blood retina barrier breakdown and neural retina damage in diabetic retinopathy","volume":"21","author":"Zhang","year":"2016","journal-title":"Discovery Medicine"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109025","article-title":"Biomarkers for primary open-angle glaucoma progression","volume":"219","author":"Zhao","year":"2022","journal-title":"Experimental Eye Research"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0845","series-title":"Craft. Gene Expression of Clusterin, Tissue Inhibitor of Metalloproteinase-1, and their Receptors in Retinal Pigment Epithelial Cells and M\u00fcller Glial Cells is Modulated by Inflammatory Stresses. Paper presented at Retinal Degenerative Diseases X; IX","author":"Zheng","year":"2026"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0850","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.neuroscience.2025.08.063","article-title":"TREM2 mediates parkinsonism-like neurodegeneration in carbon disulfide-induced neurotoxicity","volume":"585","author":"Zhidan","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2026.109108_bb0855","first-page":"2129","article-title":"Ocular clusterin expression in von Hippel-Lindau disease","volume":"13","author":"Zhou","year":"2007","journal-title":"Molecular Vision"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109108_bb0860","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41420-025-02538-1","article-title":"TREM2 deficiency exacerbates cognitive impairment by aggravating \u03b1-Synuclein-induced lysosomal dysfunction in Parkinson\u2019s disease","volume":"11","author":"Zhu","year":"2025","journal-title":"Cell Death Discovery"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600135X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600135X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:02:17Z","timestamp":1794412937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582600135X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":158,"alternative-id":["S016372582600135X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109108","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clusterin as a therapeutic agent: Bridging the gap in brain and eye research","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109108"}}